PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Diapharm Organizes API/GMP Audits - Increased Safety through Accredited, Cost-efficient Audits Published for in Europe, China and India - In 2010, the pharma service provider Diapharm is going to conduct third-party API audits in Europe, China and India. Medicinal product manufacturers in Europe must audit their API suppliers regularly, either by themselves or through a third-party
Diapharm Organizes API/GMP Audits - Increased Safety through Accredited, Cost-efficient Audits Published for in Europe, China and India

 

NewswireToday - /newswire/ - Muenster, North Rhine-Westfalia, Germany, 2010/03/08 - In 2010, the pharma service provider Diapharm is going to conduct third-party API audits in Europe, China and India. Medicinal product manufacturers in Europe must audit their API suppliers regularly, either by themselves or through a third-party.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In 2010, the pharmaceutical service provider Diapharm is again offering worldwide API/GMP audits of API manufacturing sites with a focus on Europe, China and India. Diapharm made this announcement on the occasion of the DIA Annual Euro Meeting in Monaco. During these trips, different active pharmaceutical ingredients (APIs) from different customers are audited for GMP compliance, grouped together by API manufacturing site and region. This audit sharing is extremely cost-efficient. “With these accredited third-party audits, we enable pharmaceutical companies to control their API production at the highest level,” explains Martin Vortkamp, who is in charge of the shared audit service at Diapharm. “The confidentiality interests of all participating companies have always highest priority.”

Pharmaceutical companies in Europe are obliged to guarantee the quality of their APIs used for the production of medicinal products. In order to do this, they must periodically audit their suppliers according to Good Manufacturing Practice (GMP). The growing number of CEP suspensions and revocations shows the urgency of these inspections. “Since we established this business with accredited audits in 2008, Diapharm (diapharm.com) has already audited over 50 APIs – from Alfuzosin from the Czech Republic to Venlafaxine from India,” says Martin Vortkamp. Usually the audits are performed by our partner the blue inspection body GmbH, an independent (Type A inspection body) Third-Party-Audit provider accredited according to ISO/IEC 17020 for the 'inspection of excipients and active pharmaceutical ingredient manufacturers for pharmaceutical products'. The audit reports are normally available for sale to other interested companies as well.

Additional information about planned audit trips in 2010 is available from Karin Müller, Diapharm GmbH
T: +49 (0)251 60935-511
E: karin.mueller[.]diapharm.com.

The full list of audit reports is available online.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Diapharm Organizes API/GMP Audits - Increased Safety through Accredited, Cost-efficient Audits Published for in Europe, China and India

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Christian Rieke - Co-Operate.net 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Werbeagentur & PR-Agentur co-operate securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Werbeagentur & PR-Agentur co-operate / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Rapid Recovery

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)